Envestnet Asset Management »

Denali Therapeutics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $471k 32k 14.52
2025-06-30 $469k 34k 13.99
2025-03-31 $427k 31k 13.60
2024-12-31 $767k 38k 20.38
2024-09-30 $815k 28k 29.13
2024-06-30 $491k 21k 23.22
2024-03-31 $458k 22k 20.52
2023-09-30 $477k 23k 20.63
2023-06-30 $461k 16k 29.51
2023-03-31 $955k 41k 23.04
2022-12-31 $1.1M 41k 27.81
2022-09-30 $1.3M 42k 30.69
2022-06-30 $896k 30k 29.43
2022-03-31 $1.1M 33k 32.17
2021-12-31 $1.3M 29k 44.60
2021-09-30 $1.3M 26k 50.44